A randomised, double-blind, placebo-controlled crossover trial on cannabinoid-based medication for behavioural disorders in old patients with severe dementia: the study results.
- DOI
- 10.1093/ageing/afag239
- Published
- 2026 Aug 3
- Container
- Age and ageing
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ageing/afag239,
title = {A randomised, double-blind, placebo-controlled crossover trial on cannabinoid-based medication for behavioural disorders in old patients with severe dementia: the study results.},
author = {Bianchi F and Broers B and Desmeules JA and Langlois A and Wampfler J and Curtin F and Pautex S},
year = {2026},
journal = {Age and ageing},
doi = {10.1093/ageing/afag239},
url = {https://doi.org/10.1093/ageing/afag239}
}RIS
TY - JOUR TI - A randomised, double-blind, placebo-controlled crossover trial on cannabinoid-based medication for behavioural disorders in old patients with severe dementia: the study results. AU - Bianchi F AU - Broers B AU - Desmeules JA AU - Langlois A AU - Wampfler J AU - Curtin F AU - Pautex S PY - 2026 JO - Age and ageing DO - 10.1093/ageing/afag239 UR - https://doi.org/10.1093/ageing/afag239 ER -
APA
F, B., B, B., JA, D., A, L., J, W., F, C., & S, P. (2026). A randomised, double-blind, placebo-controlled crossover trial on cannabinoid-based medication for behavioural disorders in old patients with severe dementia: the study results.. Age and ageing. https://doi.org/10.1093/ageing/afag239
Source records
- pubmed · retrieved 2026-09-25T21:37:02.817Z